Pharmesis International Statistics

Total Valuation

Pharmesis International has a market cap or net worth of SGD 18.70 million. The enterprise value is 21.59 million.

Market Cap	18.70M
Enterprise Value	21.59M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmesis International has 31.70 million shares outstanding. The number of shares has increased by 15.38% in one year.

Current Share Class	n/a
Shares Outstanding	31.70M
Shares Change (YoY)	+15.38%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	48.09%
Owned by Institutions (%)	n/a
Float	6.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.10
PB Ratio	2.00
P/TBV Ratio	2.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.64
EV / Sales	2.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.55

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.31.

Current Ratio	1.08
Quick Ratio	0.47
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-2.19
Interest Coverage	-13.26

Financial Efficiency

Return on equity (ROE) is -14.74% and return on invested capital (ROIC) is -8.61%.

Return on Equity (ROE)	-14.74%
Return on Assets (ROA)	-7.58%
Return on Capital (ROIC)	-8.61%
Revenue Per Employee	7,117
Profits Per Employee	-1,259
Employee Count	1,096
Asset Turnover	0.51
Inventory Turnover	1.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +502.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+502.04%
50-Day Moving Average	0.60
200-Day Moving Average	0.24
Relative Strength Index (RSI)	46.17
Average Volume (20 Days)	11,535

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmesis International had revenue of SGD 7.80 million and -1.38 million in losses. Loss per share was -0.05.

Revenue	7.80M
Gross Profit	2.33M
Operating Income	-1.85M
Pretax Income	-1.32M
Net Income	-1.38M
EBITDA	-1.63M
EBIT	-1.85M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 642,277 in cash and 3.05 million in debt, giving a net cash position of -2.40 million or -0.08 per share.

Cash & Cash Equivalents	642,277
Total Debt	3.05M
Net Cash	-2.40M
Net Cash Per Share	-0.08
Equity (Book Value)	9.85M
Book Value Per Share	0.30
Working Capital	362,832

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.36 million and capital expenditures -31,340, giving a free cash flow of -1.39 million.

Operating Cash Flow	-1.36M
Capital Expenditures	-31,340
Free Cash Flow	-1.39M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 29.82%, with operating and profit margins of -23.69% and -17.69%.

Gross Margin	29.82%
Operating Margin	-23.69%
Pretax Margin	-16.86%
Profit Margin	-17.69%
EBITDA Margin	-20.85%
EBIT Margin	-23.69%
FCF Margin	n/a

Dividends & Yields

Pharmesis International does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.38%
Shareholder Yield	-15.38%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on August 27, 2015. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 27, 2015
Split Type	Reverse
Split Ratio	0.1

Scores

Pharmesis International has an Altman Z-Score of -0.01. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.01
Piotroski F-Score	n/a